Skip to main content

Animations

MJFF Publications

4101 - 4110 of 8620 Results
Title
Year
  • Year
  • 2020
  • 2021
  • 2021
  • 2010
  • 2018
  • 2021
  • 2015
  • 2024
  • 2016
  • 2016
  • Summary Details
    OPEN
    Title: Subcortical Intermittent Theta-Burst Stimulation (iTBS) Increases Theta-Power in Dorsolateral Prefrontal Cortex (DLPFC)
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00041
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28549
    Citation Count: 98
  • Summary Details
    RESTRICTED
    Title: Attitudes toward use and timing of deep brain stimulation: a patient’s with DBS perspective
    Journal Name: Clinical Neurology and Neurosurgery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106553
    Best OA location URL:
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001
    Citation Count: 150
  • Summary Details
    OPEN
    Title: Movement disorders in non-encephalopathic Hashimoto's thyroiditis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.06.008
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28779
    Citation Count: 135
  • Summary Details
    RESTRICTED
    Title: Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.016
    Best OA location URL:
    Citation Count: 44
  • Summary Details
    OPEN
    Title: VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A1
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1083/jcb.202311189
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’S
    Journal Name: Personalized Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2217/pme-2016-0087
    Citation Count: 0
  • Summary Details
    OPEN
    Title: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0130-3
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.